Compugroup Medical (ETR:COP) has been given a €49.00 ($56.98) target price by Baader Bank in a report released on Thursday. The firm presently has a “neutral” rating on the stock. Baader Bank’s price target points to a potential upside of 6.20% from the company’s current price.

Several other equities analysts have also recently commented on COP. Berenberg Bank set a €49.00 ($56.98) target price on Compugroup Medical and gave the stock a “neutral” rating in a research report on Monday, July 16th. Commerzbank set a €53.00 ($61.63) target price on Compugroup Medical and gave the stock a “buy” rating in a research report on Thursday, August 9th. Warburg Research set a €53.50 ($62.21) target price on Compugroup Medical and gave the stock a “buy” rating in a research report on Friday, August 10th. Deutsche Bank set a €62.00 ($72.09) price objective on Compugroup Medical and gave the stock a “buy” rating in a report on Tuesday, August 14th. Finally, Hauck & Aufhaeuser set a €36.00 ($41.86) price objective on Compugroup Medical and gave the stock a “sell” rating in a report on Friday, August 31st. One research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. Compugroup Medical presently has an average rating of “Hold” and an average target price of €51.79 ($60.22).

Compugroup Medical stock opened at €46.14 ($53.65) on Thursday. Compugroup Medical has a 52 week low of €40.10 ($46.63) and a 52 week high of €60.30 ($70.12).

Compugroup Medical Company Profile

CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. The company's Ambulatory Information Systems segment provides practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician's networks.

Further Reading: Inflation

Analyst Recommendations for Compugroup Medical (ETR:COP)

Receive News & Ratings for Compugroup Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical and related companies with MarketBeat.com's FREE daily email newsletter.